Advertisement

The Role of Platinum-DNA Lesions in the Inhibition of DNA Replication

  • N. P. Johnson
  • J. L. Butour
  • C. Cayrol
  • S. Cros
  • M. Defais
  • J. S. Hoffmann
  • V. Pierson
  • J. P. Souchard
  • G. Villani

Abstract

Cytotoxicity and antitumor activity of platinum complexes are often sensitive to structural features of the platinum compound such as its isomerism, the number of leaving groups, and the nature of the stable ligand. Whereas cis-[Ptcl2(NH3)2] (cis-DDP) is an antitumor drug which is active against human and murine cancers, monofunctional compounds such as [PtCl(dien)]Cl and the trans isomer, trans-DDP, have no antitumor activity (Braddock et al., 1975; Macquet and Butour, 1983). During the reaction with DNA, the N(7) atoms of purine bases substitute the labile Cl ligands while the non-leaving group, NH3, remains bound to the metal. Non-leaving groups play an important role in modulating the antitumor activity of platinum compounds. For example, cell lines resistant to cis-DDP are not cross-resistant to platinum complexes with 1,2-diaminocyclohexane (DACH) (Burchenal et al., 1979). Platinum complexes with alkylamine and pyridine ligands are less antitumor than cis-DDP or inactive (Braddock et al., 1975; Meischen et al., 1976; Farrell et al., 1989).

Keywords

L1210 Cell Platinum Complex Platinum Compound Wild Type Bacterium Pyridine Ligand 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alazard, R. Germanier, M. and Johnson, N.P. (1982) Mutation Res. 93, 327–337.CrossRefGoogle Scholar
  2. Beck, D.J. and Brubaker, R.R. (1973) J. Bact. 116, 1247–1252.PubMedGoogle Scholar
  3. Brabec, V., Kleinwachter, V., Butour, J.L. and Johnson, N.P. (1990) Biophys. Chem. 35, 121–133.CrossRefGoogle Scholar
  4. Braddock, P.D., Connors, T.A., Jones, M., Khokhar, A.R., Melzack, D.H. and Tobe, M.L. (1975) Chem.-Biol. Interact. 11, 145–161.PubMedCrossRefGoogle Scholar
  5. Burchenal, J.K., Kalaher, K., Dew, K. and Lokys, L. (1979) Cancer Treat. Rep. 63, 1493–1498.PubMedGoogle Scholar
  6. Butour, J.L. and Johnson, N.P. (1986) Biochemistry 25, 4534–4539.PubMedCrossRefGoogle Scholar
  7. Butour, J.L., Mazard, A.M., Vieussens, C. and Johnson, N.P. (1990) Chem.-Biol. Interact. 73, 195–205.PubMedCrossRefGoogle Scholar
  8. Ciccarelli, R.B., Solomon, M.J., Varshavsky, A. and Lippard, S.J. (1985) Biochemistry 24, 7533–7540.PubMedCrossRefGoogle Scholar
  9. Dijt, F.J., Fichtinger-Schepman, A.M.J., Berends, F. and Reedijk, J. (1988) Cancer Res. 48, 6058–6062.PubMedGoogle Scholar
  10. Eastman, A. and Schulte, N. (1988) Biochemistry 27, 4730–4734.PubMedCrossRefGoogle Scholar
  11. Farrell, N., Ha, T.T.B., Souchard, J.P., Wimmer, F.L., Cros, S. and Johnson, N.P. (1989) J. Med. Chem. 32, 2240–2241.PubMedCrossRefGoogle Scholar
  12. Hansson, J. and Wood, R.D. (1989) Nucl. Acids Res. 17, 8073–8091.PubMedCrossRefGoogle Scholar
  13. Heiger-Bernays, W.J., Essigmann, J.M. and Lippard, S.J. (1990) Biochemistry 29, 8461–8466.PubMedCrossRefGoogle Scholar
  14. Hoffmann, J.S., Johnson, N.P. and Villani, G. (1989) J. Biol. Chem. 264, 15130–15135.PubMedGoogle Scholar
  15. Johnson, N.P., Hoeschele, J.D., Keummerle, N.B., Masker, W.E. and Rahn, R.O. (1978) Chem.-Biol. Interact. 23, 267–271.PubMedCrossRefGoogle Scholar
  16. Johnson, N.P., Hoeschele, J.D., Rahn, R.O., O’Neill, J.P. and Hsie, A.W. (1980) Cancer Res. 40, 1463–1468.PubMedGoogle Scholar
  17. Johnson, N.P., Macquet, J.P., Wiebers, J.L. and Monsarrat, B. (1982) Nucl. Acids Res. 10, 5255–5271.PubMedCrossRefGoogle Scholar
  18. Johnson, N.P., Mazard, A.M., Escalier, J. and Macquet, J.P. (1985) J. Amer. Chem. Soc. 107, 6376–6380.CrossRefGoogle Scholar
  19. Johnson, N.P., Lapetoule, P., Razaka, H. and Butour, J.L. (1988) in “Platinum and Other Metal Coordination Comounds in Cancer Chemotherapy”, ed. M. Nicolini, P. 3-15.Google Scholar
  20. Johnson, N.P., Butour, J.L., Villani, G., Wimmer, F.L., Defais, M., Pierson, V. and Brabec, V. ((1989)) Prog. Clinical Biochem. Medicine 10, 1–24.CrossRefGoogle Scholar
  21. Macquet, J.P. and Butour, J.L. (1983) J. Natl. Cancer Inst. 70, 899–905.PubMedGoogle Scholar
  22. McCarthy, S.L., Hinde, R.J., Miller, K.J., Anderson, J.S., Basch, H. and Krauss, M. (1990) Biopolymers 29, 785–790.PubMedCrossRefGoogle Scholar
  23. Meischen, S.J., Gale, G.R., Lake, L.M., Frangakis, C.J., Rosenblum, M.G., Walker, E.M. Jr., Atkins, L.M. and Smith, A.B. (1976) J., Natl. Cancer Inst. 57, 841–845.Google Scholar
  24. Ozols, R.F. (ed.) (1989) “Drug Resistance in Cancer Therapy”, Kluwer Academic Pub.Google Scholar
  25. Page, J.D., Husain, I., Sancar, A. and Chaney, S.G. (1990) Biochemistry 29, 1016–1024.PubMedCrossRefGoogle Scholar
  26. Pascoe, J.M. and Roberts, J.J. (1974) Biochem. Pharmacol. 23, 1345–1357.PubMedCrossRefGoogle Scholar
  27. Pinto, A.L. and Lippard, S.J. (1985) Proc. Natl. Acad. Sci. 82, 4616–4619.PubMedCrossRefGoogle Scholar
  28. Popoff, S.C., Beck. D.J. and Rupp, W.D. (1987) Mut. Res. 183, 129–137.CrossRefGoogle Scholar
  29. Razaka, H., Wimmer, F., Wimmer, S., Villani, G. and Johnson, N.P. (1987) Chem.-Biol. Interact. 61, 265–275.PubMedCrossRefGoogle Scholar
  30. Razaka, H., Villani, G., Hoffmann, J.S., Defais, M. and Johnson, N.P. (1988) Mut. Res. 209, 63–66.CrossRefGoogle Scholar
  31. Roberts, J.J. and Friedlos, F. (1987) Cancer Res. 47, 31–36.PubMedGoogle Scholar
  32. Salles, B. and Lesca, C. (1982) Biochem. Biophys. Res. Comm. 105, 202–208.PubMedCrossRefGoogle Scholar
  33. Souchard, J.P, Wimmer, F.L., Ha, T.T.B. and Johnson, N.P. (1990) J. Chem. Soc. Dalton Trans, 307-310.Google Scholar
  34. Souchard, J.P. (1990) PhD Thesis, Paul Sabatier University, Toulouse, France.Google Scholar
  35. Sundquist, W.I., Ahmed, K.J., Hollis, L.S. and Lippard, S.J. (1987) Inorg. Chem. 26, 1524–1528.CrossRefGoogle Scholar
  36. Walker, G.C. ((1984)), Microbiol. Revs. 48, 60–93.Google Scholar
  37. Zwelling, L.A., Filipski, J. and Kohn, K.W. (1979) Cancer Res. 39, 4989–4995.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • N. P. Johnson
    • 1
  • J. L. Butour
    • 1
  • C. Cayrol
    • 1
  • S. Cros
    • 1
  • M. Defais
    • 1
  • J. S. Hoffmann
    • 1
  • V. Pierson
    • 1
  • J. P. Souchard
    • 1
  • G. Villani
    • 1
  1. 1.Laboratoire de Pharmacologie et de ToxicologieFondamentales du CNRSToulouse CedexFrance

Personalised recommendations